Higher blood pressure in normal weight women with PCOS compared to controls
Open Access
- 1 February 2021
- journal article
- research article
- Published by Bioscientifica in Endocrine Connections
- Vol. 10 (2) , 154-163
Abstract
Objective: Obesity is considered to be the strongest predictive factor for cardio-metabolic risk in women with polycystic ovary syndrome (PCOS). The aim of the study was to compare blood pressure (BP) in normal weight women with PCOS and controls matched for age and BMI. Methods: From a Nordic cross-sectional base of 2615 individuals of Nordic ethnicity, we studied a sub cohort of 793 normal weight women with BMI < 25 kg/m2 (512 women with PCOS according to Rotterdam criteria and 281 age and BMI-matched controls). Participants underwent measurement of BP and body composition (BMI, waist-hip ratio), lipid status, and fasting BG. Data were presented as median (quartiles). Results: The median age for women with PCOS were 28 (25, 32) years and median BMI was 22.2 (20.7, 23.4) kg/m2. Systolic BP was 118 (109, 128) mmHg in women with PCOS compared to 110 (105, 120) mmHg in controls and diastolic BP was 74 (67, 81) vs 70 (64, 75) mmHg, both P < 0.001. The prevalence of women with BP ≥ 140/90 mmHg was 11.1% (57/512) in women with PCOS vs 1.8% (5/281) in controls, P < 0.001. In women ≥ 35 years the prevalence of BP ≥ 140/90 mmHg was comparable in women with PCOS and controls (12.7% vs 9.8%, P = 0.6). Using multiple regression analyses, the strongest association with BP was found for age, waist circumference, and total cholesterol in women with PCOS. Conclusions: Normal weight women with PCOS have higher BP than controls. BP and metabolic screening are relevant also in young normal weight women with PCOS.Keywords
This publication has 35 references indexed in Scilit:
- The polycystic ovary syndrome: a position statement from the European Society of EndocrinologyEuropean Journal of Endocrinology, 2014
- Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndromeHuman Reproduction, 2014
- Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleThe Lancet, 2014
- Office Blood Pressure, Ambulatory Blood Pressure Monitoring, and Echocardiographic Abnormalities in Women With Polycystic Ovary SyndromeHypertension, 2014
- The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysisObesity Reviews, 2012
- Age Associated Differences in Prevalence of Individual Rotterdam Criteria and Metabolic Risk Factors During Reproductive Age in 446 Caucasian Women with Polycystic Ovary SyndromeHormone and Metabolic Research, 2012
- Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndromeFertility and Sterility, 2011
- Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndromeHuman Reproduction, 2008
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?Human Reproduction, 1996